What is Lygos?
Lygos operates at the intersection of material science and industrial chemistry, specializing in the development of next-generation specialty chemicals. The company leverages advanced synthetic biology and chemical engineering to deliver high-performance, sustainable alternatives to traditional petrochemical-based products. By focusing on cost-effectiveness and environmental stewardship, Lygos provides essential solutions for sectors including water treatment, home care, and agronomy. Their business model is predicated on strong strategic partnerships and a commitment to driving profitability through innovation, effectively helping clients meet evolving regulatory and consumer demands for greener, more efficient materials.
How much funding has Lygos raised?
Lygos has raised a total of $30.7M across 4 funding rounds:
Series A
$14.1M
Series B
$15.5M
Debt
$350K
Debt
$760K
Series A (2016): $14.1M with participation from Lerer Ventures, First Round Capital, Fifty Years, OS Fund, and Vast Ventures
Series B (2018): $15.5M led by Y Combinator, OS Fund, Lerer Ventures, and First Round Capital
Debt (2020): $350K supported by PPP
Debt (2021): $760K featuring PPP
Key Investors in Lygos
OS Fund
OS Fund invests in entrepreneurs commercializing breakthrough discoveries in various fields, including genomics, synthetic biology, and advanced materials, with a focus on creating a better future for humanity.
Lerer Ventures
Kenneth Lerer Associates LLC is a New York-based venture capital and private equity firm that provides strategic backing to high-growth startups.
First Round Capital
A prominent venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs to achieve significant market results and successful exits.
What's next for Lygos?
Looking ahead, Lygos is positioned to leverage its recent capital injection to scale production capabilities and expand its market footprint. The strategic focus will likely center on optimizing supply chain resilience and deepening its R&D pipeline to maintain a competitive edge in the specialty chemicals landscape. As the company matures, the emphasis will shift toward commercializing new product lines and strengthening its presence in global markets that prioritize sustainability. With a proven track record of attracting high-caliber investors, Lygos is well-equipped to navigate the complexities of industrial scaling while continuing to deliver value-added solutions that redefine material performance standards.
See full Lygos company page
